LEXEO Therapeutics
Tara Hun-Dorris is a seasoned professional in medical writing and regulatory communication, currently serving as Senior Director of Medical Writing at Lexeo Therapeutics since September 2024. Prior to this role, Tara held the position of Senior Director of Medical Writing at Alpine Immune Sciences, Inc. from June 2023 to August 2024 and served as Executive Director of Medical Writing and Regulatory Intelligence at BioCryst Pharmaceuticals, Inc. from January 2018 to June 2023. Tara began her career in medical writing at Ingenix/i3 Research and later established a freelance medical writing business, THD Editorial, Inc., providing comprehensive writing and editing services. Educational credentials include a Master's degree in Mass Communication from the University of South Carolina and a Bachelor's degree in Journalism from West Virginia University.
This person is not in any teams
This person is not in any offices
LEXEO Therapeutics
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine.